TORONTO, August 26, 2020 (GLOBE NEWSWIRE) – Relay Medical Corp. (“Relay” or the “Company”) (CSE: RELA, OTC: RYMDF, Frankfurt: EIY2) and Fio Corporation (“Fio”) announce the start of fionet Rapid Response Group (“FRR”) operations to bring to market a new COVID-19 cellular tracking and tracking platform.
FRR is recently negotiating test deployments with various partners.
In the past, Relay and Fio announced a joint venture on August 19, 2020 to temporarily launch and implement a new COVID-19 reporting, knowledge collection, and testing solution. JV operates as the Fionet Rapid Response Group and is founded in Toronto, Canada.
“Community testing and real-time monitoring are essential to combat pandemics like COVID-19. Fionet has already made this imaginable in the world’s most complicated epidemic regions and we are now preparing for the imminent deployment of our platform. with several partners to combat COVID-19 at home and abroad,” said Dr. Michael Greenberg, CEO of Fionet Rapid Response Group.
You can get a photo that accompanies this ad in https://www.globenewswire.com/NewsRoom/AttachmentNg/abb3635d-6461-4211-bc08-156b57247c87
Fio’s cloud platform provides real-time actionable data to fitness supervisors and public officials to manage responses and resources with new degrees of accuracy and speed. Data and data are provided to dashboards, PC systems, and public fitness databases for fast, secure, and data-driven responses.
You can get a photo that accompanies this ad in https://www.globenewswire.com/NewsRoom/AttachmentNg/ff268b54-709f-4b8f-9d53-7358cbdcb5b7
Flexible and customizable, Fionet enables diagnostic testing in any network environment to address a variety of back-to-work use cases. Tests can be extended beyond the few overcrowded medical centers to small clinics, pharmacies, workplaces, airports, nursing homes, schools, etc.
“The numerous transformative benefits provided through Fionet have been validated and documented in dozens of medical journals and clinics. Fionet has controlled to reduce verification errors by 23%, achieved a 99.5% 1 diagnostic accuracy rate for trained lab technicians and provides significant economic power gains,” said Yoav Raiter, CHIEF Executive Officer of Relay Medical Corp.
1 Noble et al. Continuous monitoring of quality in the field: an assessment of the functionality of fio Deki Reader ™ for immediate HIV in South Africa. Infectious Diseases BMC (2020) 20: 320
2 Mulvaney SP et al. Fast design and commissioning of 4 diagnostic technologies in Sierra Leone, Thailand, Peru and Australia: successes and demanding situations found in the arrival of these biosensors. Detection and biodetection research 20 (2018) 22-33.
Companies do not explicitly or implicitly make their product have the ability to remove, cure or involve COVID-19 (or SARS-2 coronavirus) at this time.
Fio Corporation, a Toronto-based personal company, has evolved and marketed the world’s first embedded tracking and steering computing platform for decentralized physical care facilities, a new category of responses that improves the quality of physical care and reduces physical care costs. The platform allows average fitness care staff at clinics to provide a new point of diagnostic testing and controlled quality case control. At the same time, as an automated by-product of clinical use, the platform captures and provides unprecedented front-line knowledge to remote supervisors and stakeholders, enabling remote tracking, data distribution, and real-time intervention. Fio operates internationally in partnership with local organizations, services and distribution and also in partnership with other corporations that fire their technologies.
Website: www.fio.com
About Relay Medical Corp.
Relay Medical is a MedTech innovation company in Toronto, Canada, aimed at the progression of new technologies in the diagnostics and knowledge science sectors of AI.
Contact: W. Clark Kent President Office of Relay Medical Corp.647-872-9982 ext. 2 TF. 1-844-247-6633 ext. [email protected]
Bernhard Langer EU Investor Relations Office. (0) 177774 2314 Email: [email protected]
Forward-Looking Information Warning Statement
In the absence of statements of old facts, this press release includes secure “prospective data” within the meaning of applicable securities laws. Prospective data is characterized by words such as “plan,” “expect,” “project,” “pretend,” “believe,” “anticipate,” “estimate” and other similar words, or statements that sometimes or particular situations “may occur “or”. Forward-looking statements are based on revisions and estimates from the date the statements are made, and are subject to a variety of hazards and insecurities and other points that may cause actual occasions or effects to differ materially from those expected in the forecast. statements, adding, but not limited to, delays or insecurities with regulatory approvals, adding that of the CSE. There are insecurities inherent in forward-looking data, which adds points beyond the control of the company. The Company assumes no legal responsibility to update the prospective data that is covered by management’s cases or changes in estimates or revisions, unless required by law. Readers are cautioned not to place undue reliance on forward-looking statements. Additional data identifying hazards and insecurities that may have effects on monetary effects are found in the Company’s submissions to Canadian securities regulators, which can be obtained in www.sedar.com